|
1
|
Kisseleva T and Brenner D: Molecular and
cellular mechanisms of liver fibrosis and its regression. Nat Rev
Gastroenterol Hepatol. 18:151–166. 2021. View Article : Google Scholar
|
|
2
|
Hernandez-Gea V and Friedman SL:
Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011.
View Article : Google Scholar
|
|
3
|
Parola M and Pinzani M: Liver fibrosis:
Pathophysiology, pathogenetic targets and clinical issues. Mol
Aspects Med. 65:37–55. 2019. View Article : Google Scholar
|
|
4
|
Kang N, Gores GJ and Shah VH: Hepatic
stellate cells: Partners in crime for liver metastases? Hepatology.
54:707–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Trivedi P, Wang S and Friedman SL: The
power of plasticitymetabolic regulation of hepatic stellate cells.
Cell Metab. 33:242–257. 2021. View Article : Google Scholar
|
|
6
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong H, Lei J, Ding L, Wen Y, Ju H and
Zhang X: MicroRNA: Function, detection, and bioanalysis. Chem Rev.
113:6207–6233. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su T, Xiao Y, Xiao Y, Guo Q, Li C, Huang
Y, Deng Q, Wen J, Zhou F and Luo XH: Bone marrow mesenchymal stem
cells-derived exosomal MiR-29b-3p regulates aging-associated
insulin resistance. ACS Nano. 13:2450–2462. 2019.PubMed/NCBI
|
|
11
|
Xue Y, Fan X, Yang R, Jiao Y and Li Y:
miR-29b-3p inhibits post-infarct cardiac fibrosis by targeting FOS.
Biosci Rep. 40:BSR202012272020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Novo E, Cannito S, Zamara E, Valfrè di
Bonzo L, Caligiuri A, Cravanzola C, Compagnone A, Colombatto S,
Marra F, Pinzani M and Parola M: Proangiogenic cytokines as
hypoxia-dependent factors stimulating migration of human hepatic
stellate cells. Am J Pathol. 170:1942–1953. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun J, Shi L, Xiao T, Xue J, Li J, Wang P,
Wu L, Dai X, Ni X and Liu Q: microRNA-21, via the HIF-1α/VEGF
signaling pathway, is involved in arsenite-induced hepatic fibrosis
through aberrant cross-talk of hepatocytes and hepatic stellate
cells. Chemosphere. 266:1291772021. View Article : Google Scholar
|
|
14
|
Huang YH and Yeh CT: Functional
Compartmentalization of HSP60-Survivin interaction between
mitochondria and cytosol in cancer cells. Cells. 9:232019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Z, Yao Z, Zhao S, Shao J, Chen A,
Zhang F and Zheng S: Interaction between autophagy and senescence
is required for dihydroartemisinin to alleviate liver fibrosis.
Cell Death Dis. 8:e28862017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Q, Chen L, Kong D, Shao J, Wu L and
Zheng S: Dihydroartemisinin alleviates bile duct ligation-induced
liver fibrosis and hepatic stellate cell activation by interfering
with the PDGF-βR/ERK signaling pathway. Int Immunopharmacol.
34:250–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Q, Chen L, Wu X, Zhang F, Jin H, Lu
C, Shao J, Kong D, Wu L and Zheng S: Dihydroartemisinin prevents
liver fibrosis in bile duct ligated rats by inducing hepatic
stellate cell apoptosis through modulating the PI3K/Akt pathway.
IUBMB Life. 68:220–231. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Seeliger D and de Groot BL: Ligand docking
and binding site analysis with PyMOL and Autodock/Vina. J Comput
Aided Mol Des. 24:417–422. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Murakami Y, Toyoda H, Tanahashi T, Tanaka
J, Kumada T, Yoshioka Y, Kosaka N, Ochiya T and Taguchi YH:
Comprehensive miRNA expression analysis in peripheral blood can
diagnose liver disease. PLoS One. 7:e483662012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vuppalanchi R, Liang T, Goswami CP,
Nalamasu R, Li L, Jones D, Wei R, Liu W, Sarasani V, Janga SC and
Chalasani N: Relationship between differential hepatic microRNA
expression and decreased hepatic cytochrome P450 3A activity in
cirrhosis. PLoS One. 8:e744712013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blaya D, Coll M, Rodrigo-Torres D,
Vila-Casadesús M, Altamirano J, Llopis M, Graupera I, Perea L,
Aguilar-Bravo B, Díaz A, et al: Integrative microRNA profiling in
alcoholic hepatitis reveals a role for microRNA-182 in liver injury
and inflammation. Gut. 65:1535–1545. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsuura K, De Giorgi V, Schechterly C,
Wang RY, Farci P, Tanaka Y and Alter HJ: Circulating let-7 levels
in plasma and extracellular vesicles correlate with hepatic
fibrosis progression in chronic hepatitis C. Hepatology.
64:732–745. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang J, Huang J, Liu W, Ding L, Cheng D
and Xiao H: Identification of common oncogenic genes and pathways
both in osteosarcoma and Ewing's sarcoma using bioinformatics
analysis. J Immunol Res. 2022:36559082022.PubMed/NCBI
|
|
24
|
Wang Z, Zhang J, Feng T, Zhang D, Pan Y,
Liu X, Xu J, Qiao X, Cui W and Dong L: Construction of
lncRNA-Mediated competing endogenous RNA networks correlated With
T2 asthma. Front Genet. 13:8724992022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhong T, Li Z, You ZH, Nie R and Zhao H:
Predicting miRNA-disease associations based on graph random
propagation network and attention network. Brief Bioinform.
23:bbab5892022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li G, Sun J, Zhang J, Lv Y, Liu D, Zhu X,
Qi L, Chen Z, Ye Z, Su X and Li L: Identification of
Inflammation-related biomarkers in diabetes of the exocrine
pancreas with the use of weighted gene Co-Expression network
analysis. Front Endocrinol (Lausanne). 13:8398652022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mostafavi S and Morris Q: Combining many
interaction networks to predict gene function and analyze gene
lists. Proteomics. 12:1687–1696. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang S, Shen L and Luo H: Identification
and Validation of Key miRNAs and a microRNA-mRNA Regulatory Network
Associated with Ulcerative Colitis. DNA Cell Biol. 40:147–156.
2021. View Article : Google Scholar
|
|
29
|
Matsuura K, De Giorgi V, Schechterly C,
Wang RY, Farci P, Tanaka Y and Alter HJ: Circulating let-7 levels
in plasma and extracellular vesicles correlate with hepatic
fibrosis progression in chronic hepatitis C. Hepatology.
64:732–745. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xia S, Wang Z, Chen L, Zhou Y, Li Y, Wang
S, Chen A, Xu X, Shao J, Zhang Z, et al: Dihydroartemisinin
regulates lipid droplet metabolism in hepatic stellate cells by
inhibiting lncRNA-H19-induced AMPK signal. Biochem Pharmacol.
192:1147302021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cutroneo KR, White SL, Phan SH and Ehrlich
HP: Therapies for bleomycin induced lung fibrosis through
regulation of TGF-beta1 induced collagen gene expression. J Cell
Physiol. 211:585–589. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kurtz CL, Fannin EE, Toth CL, Pearson DS,
Vickers KC and Sethupathy P: Inhibition of miR-29 has a significant
lipid-lowering benefit through suppression of lipogenic programs in
liver. Sci Rep. 5:129112015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Apte RS, Chen DS and Ferrara N: VEGF in
signaling and disease: Beyond discovery and development. Cell.
176:1248–1264. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aoki M and Fujishita T: Oncogenic Roles of
the PI3K/AKT/mTOR Axis. Curr Top Microbiol Immunol. 407:153–189.
2017.PubMed/NCBI
|
|
35
|
Song YM, Lee YH, Kim JW, Ham DS, Kang ES,
Cha BS, Lee HC and Lee BW: Metformin alleviates hepatosteatosis by
restoring SIRT1-mediated autophagy induction via an AMP-activated
protein kinase-independent pathway. Autophagy. 11:46–59. 2015.
View Article : Google Scholar :
|
|
36
|
Muthusamy A, Lin CM, Shanmugam S, Lindner
HM, Abcouwer SF and Antonetti DA: Ischemia-reperfusion injury
induces occludin phosphorylation/ubiquitination and retinal
vascular permeability in a VEGFR-2-dependent manner. J Cereb Blood
Flow Metab. 34:522–531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ash D, Sudhahar V, Youn SW, Okur MN, Das
A, O'Bryan JP, McMenamin M, Hou Y, Kaplan JH, Fukai T and
Ushio-Fukai M: The P-type ATPase transporter ATP7A promotes
angiogenesis by limiting autophagic degradation of VEGFR2. Nat
Commun. 12:30912021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hunt NJ, Kang SWS, Lockwood GP, Le Couteur
DG and Cogger VC: Hallmarks of Aging in the Liver. Comput Struct
Biotechnol J. 17:1151–1161. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brenner C, Galluzzi L, Kepp O and Kroemer
G: Decoding cell death signals in liver inflammation. J Hepatol.
59:583–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Efferth T: From ancient herb to modern
drug: Artemisia annua and artemisinin for cancer therapy. Semin
Cancer Biol. 46:65–83. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Q, Ma Q, Cheng J, Zhou X, Pu W, Zhong X
and Guo X: Dihydroartemisinin as a sensitizing agent in cancer
therapies. Onco Targets Ther. 14:2563–2573. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hong DS, Kang YK, Borad M, Sachdev J,
Ejadi S, Lim HY, Brenner AJ, Park K, Lee JL, Kim TY, et al: Phase 1
study of MRX34, a liposomal miR-34a mimic, in patients with
advanced solid tumours. Br J Cancer. 122:1630–1637. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang L, Liao Y and Tang L: MicroRNA-34
family: A potential tumor suppressor and therapeutic candidate in
cancer. J Exp Clin Cancer Res. 38:532019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
van Rooij E and Kauppinen S: Development
of microRNA therapeutics is coming of age. EMBO Mol Med. 6:851–864.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Teratani T, Tomita K, Furuhashi H,
Sugihara N, Higashiyama M, Nishikawa M, Irie R, Takajo T, Wada A,
Horiuchi K, et al: Lipoprotein Lipase Up-regulation in hepatic
stellate cells exacerbates liver fibrosis in nonalcoholic
steatohepatitis in mice. Hepatol Commun. 3:1098–1112. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Duan X, Meng Q, Wang C, Liu Z, Liu Q, Sun
H, Sun P, Yang X, Huo X, Peng J and Liu K: Calycosin attenuates
triglyceride accumulation and hepatic fibrosis in murine model of
non-alcoholic steatohepatitis via activating farnesoid X receptor.
Phytomedicine. 25:83–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hu C and Jiang X: Role of NRP-1 in
VEGF-VEGFR2-Independent Tumorigenesis. Target Oncol. 11:501–505.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Simons M, Gordon E and Claesson-Welsh L:
Mechanisms and regulation of endothelial VEGF receptor signalling.
Nat Rev Mol Cell Biol. 17:611–625. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang YL, Wang FS, Lin HY and Huang YH:
Exogenous therapeutics of Microrna-29a attenuates development of
hepatic fibrosis in cholestatic animal model through regulation of
phosphoinositide 3-Kinase p85 Alpha. Int J Mol Sci. 21:36362020.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mazo DF, de Oliveira MG, Pereira IV,
Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira
Alves VA, Carrilho FJ and de Oliveira CP:
S-nitroso-N-acetylcysteine attenuates liver fibrosis in
experimental nonalcoholic steatohepatitis. Drug Des Devel Ther.
7:553–563. 2013.PubMed/NCBI
|
|
51
|
Samali A, Cai J, Zhivotovsky B, Jones DP
and Orrenius S: Presence of a pre-apoptotic complex of
pro-caspase-3, HSP60 and HSP10 in the mitochondrial fraction of
Jurkat cells. EMBO. 18:2040–2048. 1999. View Article : Google Scholar
|
|
52
|
Caruso Bavisotto C, Alberti G, Vitale AM,
Paladino L, Campanella C, Rappa F, Gorska M, Conway de Macario E,
Cappello F, Macario AJL and Marino Gammazza A: HSP60
Post-translational modifications: Functional and pathological
consequences. Front Mol Biosci. 7:952020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Macario AJ and de Macario EC: Molecular
mechanisms in chaperonopathies: Clues to understanding the
histopathological abnormalities and developing novel therapies. J
Pathol. 250:9–18. 2020. View Article : Google Scholar
|
